News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

March

23

electroCore, Inc. Announces Exclusive Distribution Agreement with Silvert Medical Nv-Sa. For Western Europe

Silvert Medical will serve as exclusive distributor of gammaCore Sapphire™ in Belgium, Luxembourg, the Netherlands, and France...

27

electroCore, Inc. Announces Inclusion of gammaCore Sapphire™ in new NHS England and NHS Improvement MedTech Funding Mandate Policy 2021/22

Policy, which goes into effect April 1, 2021, supports commissioners and providers in the...

26

electroCore, Inc. Announces Exclusive Distribution Agreement with RSK Medical Inc. in Canada

RSK Medical will serve as exclusive distributor of the gammaCore Sapphire™ in Canada, supplying therapy...

1

electroCore Announces Selection of gammaCore for National Institute on Drug Abuse (NIDA)-Sponsored Study in Opioid Use Disorders

Randomized controlled study run by Dr. Douglas Bremner at Emory University in collaboration with the Georgia Institute of Technology and...

13

electroCore Announces Second Quarter Financial Results

Received EUA and initiated gammaCore Sapphire CV distribution process for certain known or suspected...

25

electroCore Provides Update on 510(k) Submission Seeking Expanded Indication for gammaCore™

Additional information requested by FDA; Premium 2 trial progressing as planned BASKING RIDGE, N.J., Sept....

12

electroCore Announces Distribution Agreement with Doctor’s Medical LLC to Expand Patient Access to gammaCore

Exclusive contract for workers’ compensation-related injuries and injury-related headache pain BASKING RIDGE, N.J., Aug. 12,...

Recent developments